BiliCalc vs Pedia BP

BiliCalc is a neonatal bilirubin calculator and clinical reference for healthcare professionals caring for newborn infants born at 35 or more weeks of gestation. Calculations are based on the 2022 American Academy of Pediatrics (AAP) Clinical Practice Guideline for the management of hyperbilirubinemia in newborn infants 35 or more weeks of gestation. Enter the infant's postnatal age, gestational age at birth, bilirubin value, measurement type, applicable neurotoxicity risk factors, and phototherapy status to view: • Patient-specific phototherapy, escalation-of-care, and exchange-transfusion thresholds • A graph displaying the bilirubin value and applicable treatment thresholds • Guideline-based treatment recommendations • Post-discharge follow-up guidance, when applicable No internet connection is required for calculations. BiliCalc performs calculations locally on the device and can be used without Wi-Fi or cellular data. BiliCalc is designed for quick clinical reference and does not measure bilirubin. Bilirubin values and other clinical information must be obtained independently and entered by the healthcare professional. Clinical references and links to source material are available within the app. BiliCalc is intended to support, not replace, professional clinical judgment. It is independently developed and is not affiliated with, sponsored by, or endorsed by the American Academy of Pediatrics. The app itself is available in English, Spanish and Portuguese, including its interface, results, charts and clinical guidance. BiliCalc automatically uses your preferred supported device language. You can also choose a language in Info. Regional language variants are recognized, and number formatting follows your device region.

Welcome to Pedia BP. This application was designed and developed to more easily detect hypertension in children and adolescents. The blood pressure measurement calculator is developed from the National High Blood Pressure Education Program (NHBPEP,2005) Working Group on Children and Adolescents. The blood pressure measurement, SBP/DBP, are based on manual blood pressure measurements. In adolescents, BP equal to or exceeding 120/80 mmHg is prehypertension, even if this figure is less than the 90th percentile. It is critically important that hypertension and pre-hypertension are recognized and appropriately managed to decrease the risk of CAD, CVD, heart failure, CHD, and sleep apnea. Evidence shows that this problem is under-recognized due to a number of factors including lack of provider knowledge regarding the AHA blood pressure recommendations and the National High Blood Pressure Educational Program (NHBPEP) guidelines. Another issue is the complexity of factors involved in diagnosing HTN in this population delineated by the (NHBPEP) guidelines. The blood pressure tables include 1,904 variables based on gender, age, and height percentile delineated from the CDC development charts. The existing tables from The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents, which contain hundreds of normal and abnormal blood pressure values based on gender, age, and height percentile, were analyzed and streamlined into a much simplified single user interface. The application makes it easy to identify abnormal blood pressure values in almost any potential care or screening setting. This approach is ideal when blood pressure is measured in any setting. The application screening tool can aid providers in accurate and timely evaluation of pediatric blood pressure readings, as well as aid in decision making regarding best practice with regard to management of issues identified.